| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP-dependent activity | DDX19A ABCA3 HSP90B2P ABCA13 KIF4A KIF3B DDX23 CHD6 DNAH8 HSPA9 DNAH10 MYH7B MSH3 FANCM MYH14 MACF1 KIF4B MTREX HSPA14 ATP4A ATP5F1A | 2.24e-06 | 614 | 210 | 21 | GO:0140657 |
| GeneOntologyMolecularFunction | collagen binding involved in cell-matrix adhesion | 1.13e-05 | 5 | 210 | 3 | GO:0098639 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | DDX19A ABCA3 HSP90B2P ABCA13 KIF3B DDX23 CHD6 DNAH8 HSPA9 DNAH10 FANCM MACF1 MTREX HSPA14 ATP4A ATP5F1A | 1.86e-05 | 441 | 210 | 16 | GO:0016887 |
| GeneOntologyMolecularFunction | cell-matrix adhesion mediator activity | 9.19e-05 | 9 | 210 | 3 | GO:0098634 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 2.53e-04 | 118 | 210 | 7 | GO:0003774 | |
| GeneOntologyMolecularFunction | transcription factor binding | SNF8 HHEX NEK6 DGKQ NBN MEF2D STRN TRIM11 PURB MED12L CHD6 EXOSC9 KAT5 JMJD1C ZFPM2 PSIP1 BRD7 PRKDC SPEN | 3.96e-04 | 753 | 210 | 19 | GO:0008134 |
| GeneOntologyCellularComponent | integrin alpha10-beta1 complex | 9.76e-05 | 2 | 207 | 2 | GO:0034680 | |
| GeneOntologyCellularComponent | integrin alpha11-beta1 complex | 9.76e-05 | 2 | 207 | 2 | GO:0034681 | |
| Domain | - | 2.58e-05 | 6 | 206 | 3 | 3.90.1290.10 | |
| Domain | VWFA | 3.39e-05 | 82 | 206 | 7 | PS50234 | |
| Domain | VWA | 3.43e-05 | 56 | 206 | 6 | PF00092 | |
| Domain | VWA | 3.96e-05 | 84 | 206 | 7 | SM00327 | |
| Domain | Plectin | 4.48e-05 | 7 | 206 | 3 | PF00681 | |
| Domain | Plectin_repeat | 4.48e-05 | 7 | 206 | 3 | IPR001101 | |
| Domain | PLEC | 4.48e-05 | 7 | 206 | 3 | SM00250 | |
| Domain | VWF_A | 1.13e-04 | 99 | 206 | 7 | IPR002035 | |
| Domain | Striatin_N | 3.61e-04 | 3 | 206 | 2 | IPR013258 | |
| Domain | Striatin | 3.61e-04 | 3 | 206 | 2 | PF08232 | |
| Pubmed | TRAF3IP1 NHSL2 BCLAF1 KIF4A STRN KIF3B DST TMEM259 PURB STRN4 CPSF2 HSPA9 CACNA1E LIMA1 PPP1R9A HECTD4 ARHGEF12 DIDO1 PEX5L FAM81A SF3B1 ZKSCAN1 PABPC3 BRD7 ELAVL2 MACF1 ELAVL3 KIF4B | 1.43e-11 | 963 | 216 | 28 | 28671696 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | BCLAF1 EVPL DPM1 KNOP1 DST PURB CRYBG1 HSPA9 EXOSC9 LIMA1 XRN2 REXO4 RPS6KA4 DIDO1 PRC1 ZCCHC3 PPP1R10 IGF2BP2 NOP14 SF3B1 PSIP1 P4HB NOM1 MDC1 ASS1 PRKDC MTREX SPEN HSPA14 ATP4A ATP5F1A | 6.64e-11 | 1257 | 216 | 31 | 36526897 |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | BCLAF1 KIF4A NBN DPM1 ESCO1 KNOP1 DST DDX23 CHD6 CPSF2 HSPA9 NCAPD3 XRN2 KAT5 DIDO1 MSH3 PRC1 FANCM NHP2 JMJD1C PPP1R10 SF3B1 PSIP1 NOM1 RBMX2 MDC1 SUMO3 PRKDC MTREX SPEN ATP5F1A | 1.35e-10 | 1294 | 216 | 31 | 30804502 |
| Pubmed | KIF4A NBN KNOP1 STRN DST PURB STRN4 CRYBG1 CHD6 CPSF2 NCAPD3 EXOSC9 REXO4 KAT5 PPP1R9A ARHGEF12 DIDO1 NHP2 PPP1R10 NOP14 ZKSCAN1 P4HB NOM1 RBMX2 CRACDL MDC1 BRD7 KCTD3 RBM6 MACF1 MTREX SPEN ATP5F1A | 2.73e-10 | 1497 | 216 | 33 | 31527615 | |
| Pubmed | BCLAF1 ADARB1 DST UMPS HSPA9 LIMA1 XRN2 SF3B1 PSIP1 NOM1 CEP250 MDC1 MACF1 MTREX | 2.85e-10 | 234 | 216 | 14 | 36243803 | |
| Pubmed | BCLAF1 ITGB1 DPM1 ITIH3 KNOP1 COQ8A PURB MCM3AP DDX23 UMPS CPSF2 HSPA9 AGTPBP1 COL5A2 EXOSC9 REXO4 DIDO1 NHP2 PPP1R10 IGF2BP2 SF3B1 PSIP1 MYH14 P4HB NOM1 RBMX2 BRD7 SUMO3 MTREX HSPA14 ATP5F1A | 5.51e-10 | 1371 | 216 | 31 | 36244648 | |
| Pubmed | GAPVD1 KIF4A DST MCM3AP DDX23 HSPA9 XRN2 REXO4 DIDO1 ZCCHC3 IGF2BP2 NOP14 SF3B1 MYH14 P4HB MDC1 RBM6 MACF1 PRKDC MTREX SPEN | 1.01e-09 | 653 | 216 | 21 | 22586326 | |
| Pubmed | NHSL2 BCLAF1 TEX35 KNOP1 STRN DST STRN4 GTF2IRD2 DDX23 CC2D2A CHD6 DNAH8 HSPA9 CACNA1E LIMA1 MYH7B PPP1R9A SLC44A2 GTF2IRD2B NOP14 SF3B1 PSIP1 MYH14 P4HB PABPC3 RBMX2 MACF1 PRKDC SPEN ATP5F1A CFAP46 | 1.84e-09 | 1442 | 216 | 31 | 35575683 | |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | KIF4A DPM1 KNOP1 EXOC7 AGTPBP1 NCAPD3 EXOSC9 XRN2 REXO4 DIDO1 PRC1 ZCCHC3 IGF2BP2 NOP14 PSIP1 NOM1 RBM6 ELAVL2 MACF1 PRKDC MTREX HSPA14 | 2.68e-09 | 759 | 216 | 22 | 35915203 |
| Pubmed | ABCA13 BCLAF1 KIF4A ESCO1 TRIM11 DST HSPA9 XRN2 ARHGEF12 SF3B1 KIF4B RP1 ATP4A ATP5F1A | 3.51e-09 | 284 | 216 | 14 | 29459677 | |
| Pubmed | NBN DPM1 MEF2D DST PURB CHD6 DLX6 CPSF2 LIMA1 XRN2 REXO4 KAT5 DNAH10 BAG5 DIDO1 JMJD1C ZCCHC3 ZFPM2 IGF2BP2 NOP14 ZKSCAN1 MYH14 P4HB PABPC3 MDC1 BRD7 RBM6 ELAVL2 USP54 SPEN | 5.93e-09 | 1429 | 216 | 30 | 35140242 | |
| Pubmed | BCLAF1 DPM1 KNOP1 PURB DDX23 HSPA9 EXOSC9 XRN2 REXO4 PRC1 NHP2 ZCCHC3 IGF2BP2 NOP14 SF3B1 PSIP1 P4HB RBMX2 MTREX SPEN ATP5F1A | 7.34e-09 | 731 | 216 | 21 | 29298432 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | BCLAF1 KNOP1 DST DDX23 CHD6 CPSF2 XRN2 REXO4 KAT5 HECTD4 DIDO1 PPP1R10 IGF2BP2 NOP14 SF3B1 PSIP1 P4HB RBMX2 KCTD3 RBM6 ELAVL2 MACF1 ELAVL3 PRKDC SPEN | 1.96e-08 | 1082 | 216 | 25 | 38697112 |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | GAPVD1 KIF4A UMPS CPSF2 NCAPD3 EXOSC9 DIDO1 MSH3 PRC1 SF3B1 P4HB MDC1 ASS1 PRKDC | 2.52e-08 | 332 | 216 | 14 | 32786267 |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | DDX19A GAPVD1 BCLAF1 ITGB1 DST DDX23 CPSF2 HSPA9 EXOSC9 LIMA1 XRN2 PPP1R9A PPP1R10 IGF2BP2 SF3B1 PSIP1 MYH14 P4HB MDC1 MACF1 PRKDC MTREX SPEN ATP5F1A | 2.94e-08 | 1024 | 216 | 24 | 24711643 |
| Pubmed | NBN ITGB1 PURB DDX23 LIMA1 XRN2 DIDO1 MSH3 PPP1R10 SF3B1 PSIP1 MDC1 PRKDC MTREX | 3.39e-08 | 340 | 216 | 14 | 24332808 | |
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | BCLAF1 NBN PURB MCM3AP DDX23 CPSF2 NCAPD3 DIDO1 JMJD1C PPP1R10 NOP14 MDC1 MTREX SPEN | 3.52e-08 | 341 | 216 | 14 | 32971831 |
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | BCLAF1 ADARB1 PURB DDX23 HSPA9 XRN2 REXO4 DIDO1 ZCCHC3 PPP1R10 IGF2BP2 NOP14 SF3B1 PSIP1 P4HB NOM1 RBM6 ELAVL2 MACF1 PRKDC SPEN | 3.99e-08 | 807 | 216 | 21 | 22681889 |
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | BCLAF1 KNOP1 DDX23 CPSF2 HSPA9 XRN2 REXO4 IGF2BP2 NOP14 SF3B1 PSIP1 ZKSCAN1 NOM1 MDC1 PRKDC MTREX SPEN ATP5F1A | 5.41e-08 | 605 | 216 | 18 | 28977666 |
| Pubmed | A Global Analysis of the Receptor Tyrosine Kinase-Protein Phosphatase Interactome. | TRAF3IP1 BCLAF1 LRP8 TYRO3 CHD6 DNAH8 HSPA9 AGTPBP1 BAG5 HEXD SNX29 PPM1B SMTNL1 TIE1 SPEN | 7.05e-08 | 420 | 216 | 15 | 28065597 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | FILIP1 GAPVD1 BCLAF1 NBN ADARB1 MEF2D PURB CPSF2 AGTPBP1 NCAPD3 LIMA1 XRN2 DIDO1 SF3B1 PSIP1 RBMX2 MDC1 RBM6 PRKDC SPEN | 9.55e-08 | 774 | 216 | 20 | 15302935 |
| Pubmed | Expression of testicular germ cell genes identified by differential display analysis. | 9.93e-08 | 8 | 216 | 4 | 12634303 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | GAPVD1 NANP BCLAF1 SPART KIF4A NBN TTC1 KNOP1 DST HSPA9 CNN3 PSAT1 LIMA1 DIDO1 SNX29 PPP1R10 IGF2BP2 SF3B1 PSIP1 MACF1 PRKDC ATP5F1A | 1.06e-07 | 934 | 216 | 22 | 33916271 |
| Pubmed | Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15. | BCLAF1 DDX23 CPSF2 HSPA9 PSAT1 LIMA1 XRN2 ZCCHC3 IGF2BP2 SF3B1 PSIP1 P4HB ASS1 RBM6 ELAVL2 ELAVL3 PRKDC MTREX ATP5F1A | 1.29e-07 | 714 | 216 | 19 | 28302793 |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | BCLAF1 KIF4A NBN MEF2D KNOP1 DLX6 EXOSC9 XRN2 REXO4 DIDO1 FANCM JMJD1C PPP1R10 SF3B1 PSIP1 PABPC3 MDC1 BRD7 RBM6 PRKDC SPEN ATP5F1A | 1.52e-07 | 954 | 216 | 22 | 36373674 |
| Pubmed | GAPVD1 TTC1 STRN DST STRN4 LIMA1 PPP1R9A BAG5 ANKRD44 IGF2BP2 ASS1 PRKDC USP54 MTREX SH3RF3 | 1.53e-07 | 446 | 216 | 15 | 24255178 | |
| Pubmed | 2.36e-07 | 3 | 216 | 3 | 26148229 | ||
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | BCLAF1 KIF4A EXOSC9 REXO4 DIDO1 JMJD1C PPP1R10 SF3B1 PSIP1 MDC1 PRKDC SPEN | 2.42e-07 | 283 | 216 | 12 | 30585729 |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | KIF4A KNOP1 CHD6 DLX6 REXO4 DIDO1 MSH3 NHP2 JMJD1C PPP1R10 NOP14 PSIP1 RBMX2 MDC1 BRD7 SUMO3 SPEN | 3.07e-07 | 608 | 216 | 17 | 36089195 |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | GAPVD1 KIF4A ITGB1 MEF2D CPSF2 ANKRD20A1 AGTPBP1 NCAPD3 KAT5 MSH3 SIM2 PRC1 NHP2 JMJD1C SH2B1 NOP14 SF3B1 PSIP1 SPEN HSPA14 | 4.78e-07 | 857 | 216 | 20 | 25609649 |
| Pubmed | TRAF3IP1 NCKAP5 ADARB1 DPM1 NAA25 DST CHD6 EXOC7 HSPA9 AGTPBP1 EXOSC9 XRN2 HECTD4 MSH3 SIM2 NHP2 CFAP298 SH2B1 SF3B1 MYH14 MACF1 SUMO3 PRKDC USP54 ATP5F1A | 5.03e-07 | 1285 | 216 | 25 | 35914814 | |
| Pubmed | DDX19A ADARB1 KIF3B DST PURB DDX23 CPSF2 CNN3 XRN2 REXO4 KAT5 PRC1 NHP2 IGF2BP2 PABPC3 RBM6 ELAVL2 ELAVL3 | 7.33e-07 | 723 | 216 | 18 | 34133714 | |
| Pubmed | MDC1 regulates DNA-PK autophosphorylation in response to DNA damage. | 9.41e-07 | 4 | 216 | 3 | 15377652 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | DDX19A GAPVD1 BCLAF1 DPM1 CC2D2A HSPA9 CA2 NCAPD3 PSAT1 EXOSC9 XRN2 REXO4 DNAH10 MSH3 PRC1 NHP2 SF3B1 GUCY1B2 PSIP1 MYH14 P4HB MDC1 PRKDC MTREX SPEN ATP5F1A | 9.75e-07 | 1425 | 216 | 26 | 30948266 |
| Pubmed | Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing. | KIF4A NBN ADARB1 KNOP1 HSPA9 LIMA1 XRN2 DIDO1 SF3B1 MDC1 ELAVL3 | 1.19e-06 | 271 | 216 | 11 | 32433965 |
| Pubmed | 1.56e-06 | 129 | 216 | 8 | 28973437 | ||
| Pubmed | CCPG1 BCLAF1 EVPL DPM1 KNOP1 NCAPD3 EXOSC9 LIMA1 XRN2 REXO4 NHP2 IGF2BP2 NOP14 PSIP1 MYH14 NOM1 MDC1 PRKDC MTREX | 1.67e-06 | 847 | 216 | 19 | 35850772 | |
| Pubmed | BCLAF1 DDX23 HSPA9 CA2 EXOSC9 LIMA1 XRN2 ZCCHC3 PPM1B IGF2BP2 SF3B1 P4HB PRKDC MTREX ATP5F1A | 2.15e-06 | 551 | 216 | 15 | 34728620 | |
| Pubmed | Citrullination of collagen II affects integrin-mediated cell adhesion in a receptor-specific manner. | 2.34e-06 | 5 | 216 | 3 | 24823363 | |
| Pubmed | ZNF142 EVPL NCKAP5 TTC1 MEF2D MAP3K4 DST MCM3AP CHD6 EXOSC9 SF3B1 CEP250 MACF1 PRKDC | 2.48e-06 | 486 | 216 | 14 | 20936779 | |
| Pubmed | Poly(ADP-ribosyl)ation of BRD7 by PARP1 confers resistance to DNA-damaging chemotherapeutic agents. | BCLAF1 DPM1 HSPA9 NCAPD3 EXOSC9 LIMA1 XRN2 IGF2BP2 SF3B1 NOM1 RBMX2 BRD7 PRKDC ATP5F1A | 2.48e-06 | 486 | 216 | 14 | 30940648 |
| Pubmed | 2.84e-06 | 187 | 216 | 9 | 26460568 | ||
| Pubmed | BCLAF1 EVPL DST HSPA9 CNN3 LIMA1 PPP1R9A DIDO1 MSH3 P4HB MACF1 PRKDC | 3.01e-06 | 360 | 216 | 12 | 33111431 | |
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | ABCA13 BCLAF1 ARHGEF12 DIDO1 JMJD1C SF3B1 MDC1 MACF1 ELAVL3 PRKDC SPEN ATP4A | 3.10e-06 | 361 | 216 | 12 | 26167880 |
| Pubmed | GAPVD1 BCLAF1 KIF4A ITGB1 DPM1 MEF2D ERAP2 HSPA9 PSAT1 LIMA1 BAG5 SIM2 PPM1B IGF2BP2 SF3B1 MYH14 P4HB WDR87 ASS1 NPRL3 PRKDC MTREX ATP5F1A | 3.61e-06 | 1247 | 216 | 23 | 27684187 | |
| Pubmed | ABCA13 BCLAF1 NBN EVPL DDX23 HSPA9 DIDO1 FANCM SF3B1 PSIP1 MYH14 P4HB MDC1 PRKDC MTREX ATP5F1A | 3.71e-06 | 652 | 216 | 16 | 31180492 | |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | DDX19A KIF4A NBN MED12L DDX23 UMPS CPSF2 EXOC7 GULP1 XRN2 SF3B1 BRD7 MACF1 PRKDC MTREX | 4.18e-06 | 582 | 216 | 15 | 20467437 |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | BCLAF1 KIF4A DDX23 HSPA9 CNN3 EXOSC9 XRN2 REXO4 DIDO1 PRC1 JMJD1C PPP1R10 NOP14 SF3B1 P4HB MDC1 RBM6 PRKDC MTREX ATP5F1A | 4.21e-06 | 989 | 216 | 20 | 36424410 |
| Pubmed | BCLAF1 KIF4A DST DDX23 LIMA1 XRN2 MSH3 PRC1 NHP2 PPM1B SF3B1 MDC1 MACF1 PRKDC MTREX CDK6 | 4.32e-06 | 660 | 216 | 16 | 32780723 | |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | GAPVD1 BCLAF1 MAP3K4 EXOSC9 XRN2 HECTD4 PRC1 MYH14 MDC1 BRD7 RBM6 USP54 MTREX | 4.34e-06 | 440 | 216 | 13 | 34244565 |
| Pubmed | ATPase-Modulated Stress Granules Contain a Diverse Proteome and Substructure. | DDX19A ITGB1 DST PURB HSPA9 CNN3 PPP1R10 IGF2BP2 ELAVL2 MACF1 ATP5F1A | 5.04e-06 | 315 | 216 | 11 | 26777405 |
| Pubmed | Charting the landscape of tandem BRCT domain-mediated protein interactions. | DDX19A BCLAF1 SELENOV STRN STRN4 DDX23 CPSF2 NCAPD3 LIMA1 FANCM ANKRD44 NOP14 MYH14 NOM1 MDC1 HSPA14 | 5.22e-06 | 670 | 216 | 16 | 22990118 |
| Pubmed | Functional specialization of beta-arrestin interactions revealed by proteomic analysis. | BCLAF1 HSPA9 LIMA1 ARHGEF12 PPM1B IGF2BP2 SF3B1 P4HB PABPC3 KCTD3 ATP5F1A | 5.35e-06 | 317 | 216 | 11 | 17620599 |
| Pubmed | GAPVD1 BCLAF1 SPART ADCY9 DST COQ8A MED12L CPSF2 NCAPD3 HECTD4 DIDO1 MDC1 SLIT3 MTREX | 6.53e-06 | 529 | 216 | 14 | 14621295 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | NEK6 ITGB1 ADARB1 ESCO1 ITPKB LRP8 JAK2 COQ8A KATNIP CHD6 GULP1 PSAT1 PPP1R9A HECTD4 JMJD1C SNX29 SH2B1 ANKRD44 MYH14 ASS1 USP40 TTC21B RBM6 MACF1 SH3RF3 | 6.84e-06 | 1489 | 216 | 25 | 28611215 |
| Pubmed | The deubiquitinase TRABID stabilizes the K29/K48-specific E3 ubiquitin ligase HECTD1. | 7.87e-06 | 212 | 216 | 9 | 33853758 | |
| Pubmed | BCLAF1 NBN HSPA9 NCAPD3 DIDO1 PRC1 ZCCHC3 PSIP1 MDC1 PRKDC SPEN ATP5F1A | 7.91e-06 | 396 | 216 | 12 | 26687479 | |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | BCLAF1 DPM1 DST DDX23 HSPA9 LIMA1 XRN2 RPS6KA4 PPP1R9A PRC1 SF3B1 PSIP1 MYH14 NOM1 RBMX2 MDC1 ASS1 PRKDC ATP5F1A | 8.51e-06 | 949 | 216 | 19 | 36574265 |
| Pubmed | KNOP1 CRYBG1 CHD6 EXOSC9 XRN2 FAM81A ZCCHC3 ZFPM2 PPP1R10 PSIP1 NOM1 BRD7 SPEN | 8.60e-06 | 469 | 216 | 13 | 27634302 | |
| Pubmed | ATG5 is required for B cell polarization and presentation of particulate antigens. | HSP90B2P DPM1 STRN PLCG2 CPSF2 HSPA9 MICAL1 LIMA1 XRN2 PRC1 NHP2 ANKRD44 PABPC3 RBMX2 MTREX ATP5F1A | 9.17e-06 | 701 | 216 | 16 | 30196744 |
| Pubmed | Mutual regulation between OGT and XIAP to control colon cancer cell growth and invasion. | BCLAF1 ECSIT KNOP1 TRIM11 UMPS HSPA9 XRN2 REXO4 PRC1 ZCCHC3 IGF2BP2 PSIP1 P4HB NOM1 HSPA14 ATP5F1A | 9.67e-06 | 704 | 216 | 16 | 32994395 |
| Pubmed | HSP90B2P PURB HSPA9 CNN3 CA2 PSAT1 LIMA1 CRYBA4 PSIP1 MYH14 P4HB PABPC3 ASS1 ATP5F1A | 1.05e-05 | 552 | 216 | 14 | 36293380 | |
| Pubmed | HSP90B2P BCLAF1 ITPKB STRN DST PURB STRN4 HSPA9 AGTPBP1 CA2 MICAL1 LIMA1 PPP1R9A ARHGEF12 SF3B1 MYH14 P4HB PABPC3 CRACDL MACF1 ELAVL3 USP54 ATP5F1A CACNA2D3 | 1.08e-05 | 1431 | 216 | 24 | 37142655 | |
| Pubmed | Mouse screen reveals multiple new genes underlying mouse and human hearing loss. | SNF8 STIMATE DENND1C ANKS4B DPM1 ESCO1 ADCY9 TRIM11 KIF3B CC2D2A ECI2 PSAT1 EXOSC9 MYH7B NHP2 JMJD1C MYH14 NOM1 CRACDL CEP250 BRD7 ATP5F1A | 1.12e-05 | 1242 | 216 | 22 | 30973865 |
| Pubmed | 1.14e-05 | 222 | 216 | 9 | 35941108 | ||
| Pubmed | BCLAF1 ECSIT ITGB1 DPM1 DST COQ8A TMEM259 PURB DDX23 UMPS EXOC7 NCAPD3 PSAT1 EXOSC9 XRN2 BAG5 IGF2BP2 SF3B1 PSIP1 NOM1 MDC1 PRKDC MTREX ATP5F1A | 1.19e-05 | 1440 | 216 | 24 | 30833792 | |
| Pubmed | SPART NBN COQ8A STRN4 DDX23 EXOC7 HSPA9 CNN3 EXOSC9 LIMA1 MSH3 PPP1R10 MTREX ATP5F1A | 1.24e-05 | 560 | 216 | 14 | 35241646 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | DDX19A KIF4A DPM1 DST MCM3AP DDX23 PLCG2 HSPA9 XRN2 REXO4 MSH3 NHP2 IGF2BP2 NOP14 SF3B1 MYH14 P4HB MDC1 ASS1 MACF1 PRKDC MTREX ATP5F1A | 1.34e-05 | 1353 | 216 | 23 | 29467282 |
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | GAPVD1 EVPL ITGB1 ADCY9 DST NECTIN1 CRYBG1 CNN3 LIMA1 LRRC57 ARHGEF12 TENM3 PLEKHO2 MACF1 | 1.36e-05 | 565 | 216 | 14 | 25468996 |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | GAPVD1 DPM1 MAP3K4 DDX23 COL5A2 COL6A6 PCDHB9 NHP2 PPP1R10 XIRP2 ASS1 RP1 SH3RF3 | 1.58e-05 | 497 | 216 | 13 | 36774506 |
| Pubmed | Systematic Analysis of Human Protein Phosphatase Interactions and Dynamics. | ECSIT ITGB1 STRN STRN4 LIMA1 PPP1R9A BAG5 ANKRD44 PPP1R10 SF3B1 P4HB KCTD3 PRKDC MTREX | 1.59e-05 | 573 | 216 | 14 | 28330616 |
| Pubmed | BCLAF1 KIF4A NBN TRIM11 DDX23 CPSF2 XRN2 KAT5 DIDO1 MSH3 PRC1 PPP1R10 SF3B1 PSIP1 MDC1 ASS1 SUMO3 PRKDC MTREX | 2.13e-05 | 1014 | 216 | 19 | 32416067 | |
| Pubmed | ABCA13 BCLAF1 DST HSPA9 AGTPBP1 LIMA1 PPM1B SF3B1 P4HB MDC1 TTC21B PRKDC ATP5F1A | 2.20e-05 | 513 | 216 | 13 | 25798074 | |
| Pubmed | SPART FAM161B STRN KIF3B DST MCM3AP CHD6 PLCG2 PPP1R10 SF3B1 TENM3 NOM1 CEP250 MACF1 | 2.24e-05 | 591 | 216 | 14 | 15231748 | |
| Pubmed | 2.38e-05 | 55 | 216 | 5 | 27114453 | ||
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | SPART NBN ITGB1 MEF2D STRN EXOSC9 LIMA1 JMJD1C PPP1R10 SF3B1 MYH14 SUMO3 | 2.45e-05 | 444 | 216 | 12 | 34795231 |
| Pubmed | TXLNA enhances TBK1 phosphorylation by suppressing PPM1B recruitment. | 2.63e-05 | 138 | 216 | 7 | 37506885 | |
| Pubmed | Spatiotemporal distribution of SUMOylation components during mouse brain development. | 2.75e-05 | 10 | 216 | 3 | 24639124 | |
| Pubmed | 2.78e-05 | 191 | 216 | 8 | 33762435 | ||
| Pubmed | GAPVD1 CCPG1 NBEAL1 DPM1 STRN KIF3B PURB STRN4 UMPS COL5A2 NCAPD3 ZCCHC3 PPP1R10 ZKSCAN1 P4HB | 3.02e-05 | 689 | 216 | 15 | 36543142 | |
| Pubmed | SND1 binds SARS-CoV-2 negative-sense RNA and promotes viral RNA synthesis through NSP9. | 3.72e-05 | 258 | 216 | 9 | 37794589 | |
| Pubmed | 3.76e-05 | 11 | 216 | 3 | 36427672 | ||
| Pubmed | KIF4 regulates neuronal morphology and seizure susceptibility via the PARP1 signaling pathway. | 3.84e-05 | 2 | 216 | 2 | 36482480 | |
| Pubmed | 3.84e-05 | 2 | 216 | 2 | 23594705 | ||
| Pubmed | Marking and measuring single microtubules by PRC1 and kinesin-4. | 3.84e-05 | 2 | 216 | 2 | 23870126 | |
| Pubmed | 3.84e-05 | 2 | 216 | 2 | 11002341 | ||
| Pubmed | alpha 11beta 1 integrin recognizes the GFOGER sequence in interstitial collagens. | 3.84e-05 | 2 | 216 | 2 | 12496264 | |
| Pubmed | The multiple functions of kinesin-4 family motor protein KIF4 and its clinical potential. | 3.84e-05 | 2 | 216 | 2 | 30081192 | |
| Pubmed | DNA-dependent protein kinase is a context dependent regulator of Lmx1a and midbrain specification. | 3.84e-05 | 2 | 216 | 2 | 24194952 | |
| Pubmed | Chromokinesin Kif4 promotes proper anaphase in mouse oocyte meiosis. | 3.84e-05 | 2 | 216 | 2 | 31067151 | |
| Pubmed | CDK6 coordinates JAK2 V617F mutant MPN via NF-κB and apoptotic networks. | 3.84e-05 | 2 | 216 | 2 | 30635286 | |
| Pubmed | 3.84e-05 | 2 | 216 | 2 | 10464311 | ||
| Pubmed | 3.84e-05 | 2 | 216 | 2 | 9343427 | ||
| Pubmed | The MEF2D transcription factor mediates stress-dependent cardiac remodeling in mice. | 3.84e-05 | 2 | 216 | 2 | 18079970 | |
| Pubmed | Cellular motor protein KIF-4 associates with retroviral Gag. | 3.84e-05 | 2 | 216 | 2 | 10559369 | |
| Pubmed | 3.84e-05 | 2 | 216 | 2 | 10486209 | ||
| Pubmed | 3.84e-05 | 2 | 216 | 2 | 21565503 | ||
| Pubmed | Stromal Integrin α11β1 Affects RM11 Prostate and 4T1 Breast Xenograft Tumors Differently. | 3.84e-05 | 2 | 216 | 2 | 26990302 | |
| Pubmed | 3.84e-05 | 2 | 216 | 2 | 7929562 | ||
| Pubmed | 3.84e-05 | 2 | 216 | 2 | 12787314 | ||
| Interaction | BMI1 interactions | BCLAF1 NBN EVPL ADARB1 DPM1 DST PURB DDX23 LIMA1 XRN2 KAT5 DIDO1 NHP2 ZCCHC3 IGF2BP2 NOP14 P4HB PABPC3 KCTD3 NPRL3 RBM6 ELAVL2 PRKDC MTREX SPEN | 2.38e-08 | 659 | 209 | 25 | int:BMI1 |
| Interaction | MYCN interactions | BCLAF1 ADARB1 DPM1 KNOP1 PURB DDX23 DLX6 CPSF2 HSPA9 NCAPD3 LIMA1 XRN2 REXO4 DIDO1 PRC1 NHP2 ZCCHC3 IGF2BP2 NOP14 SF3B1 PSIP1 MYH14 P4HB NOM1 RBMX2 BRD7 ASS1 RBM6 ELAVL2 ELAVL3 PRKDC MTREX ATP5F1A | 5.20e-06 | 1373 | 209 | 33 | int:MYCN |
| Interaction | CDC5L interactions | DDX19A TRAF3IP1 KIF4A NBN DST MED12L DDX23 UMPS CPSF2 EXOC7 GULP1 XRN2 BAG5 PRC1 NOP14 SF3B1 MDC1 BRD7 RBM6 ELAVL2 MACF1 PRKDC MTREX SPEN | 9.62e-06 | 855 | 209 | 24 | int:CDC5L |
| Interaction | ITGA10 interactions | 1.08e-05 | 5 | 209 | 3 | int:ITGA10 | |
| Interaction | ANKRD20A4P interactions | 2.15e-05 | 6 | 209 | 3 | int:ANKRD20A4P | |
| Interaction | PAXIP1 interactions | BCLAF1 NBN ECSIT SELENOV STRN STRN4 DDX23 UMPS NCAPD3 LIMA1 NOP14 NOM1 MDC1 HSPA14 | 2.45e-05 | 359 | 209 | 14 | int:PAXIP1 |
| Interaction | MEN1 interactions | CCPG1 BCLAF1 NBN DPM1 MEF2D KNOP1 PURB MCM3AP DDX23 CPSF2 NCAPD3 EXOSC9 XRN2 REXO4 DIDO1 NHP2 JMJD1C PPP1R10 IGF2BP2 NOP14 PSIP1 MYH14 NOM1 MDC1 MTREX SPEN | 2.50e-05 | 1029 | 209 | 26 | int:MEN1 |
| Interaction | SIRT7 interactions | GAPVD1 KIF4A DST MCM3AP DDX23 HSPA9 XRN2 REXO4 DIDO1 ZCCHC3 IGF2BP2 NOP14 SF3B1 MYH14 P4HB MDC1 RBM6 MACF1 PRKDC MTREX SPEN | 3.31e-05 | 744 | 209 | 21 | int:SIRT7 |
| Interaction | ANKRD20A2P interactions | 3.73e-05 | 7 | 209 | 3 | int:ANKRD20A2P | |
| Interaction | RSL1D1 interactions | BCLAF1 ADARB1 KNOP1 ADH6 TRIM11 DST PURB DDX23 REXO4 SLC44A2 PRC1 ZCCHC3 NOP14 SF3B1 BRD7 ELAVL2 | 4.25e-05 | 479 | 209 | 16 | int:RSL1D1 |
| Interaction | ZC3H18 interactions | BCLAF1 DPM1 KNOP1 PURB DDX23 HSPA9 EXOSC9 XRN2 REXO4 PRC1 NHP2 ZCCHC3 IGF2BP2 NOP14 SF3B1 PSIP1 P4HB RBMX2 RBM6 ELAVL2 MTREX SPEN ATP5F1A | 4.31e-05 | 877 | 209 | 23 | int:ZC3H18 |
| Interaction | SUMO2 interactions | GAPVD1 KIF4A NBN DST UMPS CPSF2 HSPA9 NCAPD3 EXOSC9 DIDO1 MSH3 PRC1 SF3B1 P4HB MDC1 ASS1 SUMO3 PRKDC | 4.70e-05 | 591 | 209 | 18 | int:SUMO2 |
| Interaction | ECT2 interactions | ZNF142 ABCA13 BCLAF1 FAM161B STRN DST DDX23 CPSF2 COL5A2 EXOSC9 LIMA1 XRN2 PPP1R9A FANCM IGF2BP2 SF3B1 MYH14 P4HB PABPC3 MDC1 MACF1 PRKDC ATP5F1A | 5.13e-05 | 887 | 209 | 23 | int:ECT2 |
| Interaction | H3C1 interactions | KIF4A NBN ESCO1 KNOP1 DNAH8 PLCZ1 EXOSC9 REXO4 KAT5 DIDO1 MSH3 PRC1 JMJD1C SF3B1 PSIP1 XIRP2 MYH14 WDR87 PABPC3 MDC1 BRD7 PRKDC SPEN | 6.50e-05 | 901 | 209 | 23 | int:H3C1 |
| Cytoband | 3p21.1 | 4.64e-05 | 42 | 216 | 4 | 3p21.1 | |
| Cytoband | 13q13.3 | 3.43e-04 | 29 | 216 | 3 | 13q13.3 | |
| Cytoband | 9p12 | 3.43e-04 | 29 | 216 | 3 | 9p12 | |
| GeneFamily | EF-hand domain containing|Plakins | 2.80e-05 | 8 | 146 | 3 | 939 | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | NHSL2 ADARB1 MEOX2 DST COL5A2 COL6A6 ZFPM2 TENM3 SLIT3 MACF1 | 2.84e-08 | 187 | 216 | 10 | 92d468dde81125d51daf7abd4703741abe1ab91c |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | NHSL2 ADARB1 MEOX2 DST COL5A2 COL6A6 ZFPM2 TENM3 SLIT3 SH3RF3 | 3.31e-08 | 190 | 216 | 10 | 3a42a9b98d954685d38a741f44545898d0e3e9ce |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | NHSL2 ADARB1 MEOX2 DST COL5A2 COL6A6 ZFPM2 TENM3 SLIT3 MACF1 | 3.47e-08 | 191 | 216 | 10 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | NHSL2 ADARB1 MEOX2 DST COL5A2 COL6A6 ZFPM2 TENM3 SLIT3 MACF1 | 3.65e-08 | 192 | 216 | 10 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | NCKAP5 ITPKB DST SHE PPP1R9A ARHGEF12 ZFPM2 IGF2BP2 TIE1 MACF1 | 4.03e-08 | 194 | 216 | 10 | 0b9cd96fa0b616da7cc90e92ff71157e9bba518f |
| ToppCell | Bronchial-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | NHSL2 ADARB1 MEOX2 DST COL5A2 COL6A6 ZFPM2 TENM3 SLIT3 SH3RF3 | 5.36e-08 | 200 | 216 | 10 | 389cc775c8419d90fb77cd794376d2160a7bf44e |
| ToppCell | Parenchymal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | NHSL2 ADARB1 MEOX2 DST COL5A2 COL6A6 ZFPM2 TENM3 SLIT3 SH3RF3 | 5.36e-08 | 200 | 216 | 10 | cf433f9b43d7db07acaf70e060f8f77c974e72f3 |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | NHSL2 ADARB1 MEOX2 DST COL5A2 COL6A6 ZFPM2 TENM3 SLIT3 SH3RF3 | 5.36e-08 | 200 | 216 | 10 | cae972324d1dfea6efeaf6013f265c7c6bb48db4 |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | NHSL2 ADARB1 MEOX2 DST COL5A2 COL6A6 ZFPM2 TENM3 SLIT3 SH3RF3 | 5.36e-08 | 200 | 216 | 10 | 311fab076f2ceb258e3970eb21e39344b894042a |
| ToppCell | COPD-Myeloid-cDC1|World / Disease state, Lineage and Cell class | ANKRD20A2P NCKAP5 ANKRD20A3P ANKRD20A8P DST ANKRD20A4P MED12L CRYBG1 ANKRD20A1 | 3.03e-07 | 184 | 216 | 9 | 42d7ce104cd7bcb83fbbbd0e7d3267ad07edfa94 |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | TRAF3IP1 ABCA13 CYP24A1 KIF3B CC2D2A STOML3 CCDC157 DNAH10 RP1 | 3.80e-07 | 189 | 216 | 9 | b4b93bd10b7e3cc16e54ff73beac230f519c010a |
| ToppCell | COPD-Myeloid-cDC1|Myeloid / Disease state, Lineage and Cell class | ANKRD20A2P NCKAP5 ANKRD20A3P ANKRD20A8P ANKRD20A4P MED12L CRYBG1 ANKRD20A1 CDK6 | 4.15e-07 | 191 | 216 | 9 | 3480e6d27dd4291765bbbb2acdb6a2e4f02c8085 |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | ARHGAP42 COL6A5 ADARB1 MEOX2 GULP1 COL5A2 COL6A6 TENM3 SLIT3 | 4.34e-07 | 192 | 216 | 9 | 3d0cb19f037f604253d7d728689aeaa94251e92b |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.34e-07 | 192 | 216 | 9 | deeecd26972241846b4cb998edf0c7a87ff0c4df | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D231|Adult / Lineage, Cell type, age group and donor | 4.53e-07 | 193 | 216 | 9 | ef2f456c094e6e3c6ee81e0668c953cb8d0e1c0a | |
| ToppCell | Control-Fibroblasts-Intermediate_pathological_FB|Control / group, cell type (main and fine annotations) | 4.73e-07 | 194 | 216 | 9 | 03a269f75a481ea54aea8e6444605db8d6df493d | |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | 4.94e-07 | 195 | 216 | 9 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 | |
| ToppCell | facs-Trachea-3m|Trachea / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.38e-07 | 197 | 216 | 9 | e77016d64b1cac9825fec7cfe5071f1567401187 | |
| ToppCell | facs-Trachea-nan-3m|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.38e-07 | 197 | 216 | 9 | 0353d925ee4b7aefc2c51b5fab873f465cdf9ebc | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | FILIP1 NHSL2 ADARB1 COL5A2 COL6A6 ZFPM2 SLC14A2 SH3RF3 CACNA2D3 | 5.38e-07 | 197 | 216 | 9 | 0dd71e399f253787fa546a7e90c5373180b89ffd |
| ToppCell | COVID-19-lung-Fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.61e-07 | 198 | 216 | 9 | 3ec01a55ade5e1627258cc3cfebb2c3207a4cb43 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 5.61e-07 | 198 | 216 | 9 | 17dc055e2a289496d9c5cdbf3297bdf906dc6d22 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 5.85e-07 | 199 | 216 | 9 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.10e-07 | 200 | 216 | 9 | 34f52003988ce6329d8deeee1ab875fa77e01e9d | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.10e-07 | 200 | 216 | 9 | e8462395fee0a532d1e7ec7f1795f28c42af6541 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.23e-07 | 147 | 216 | 8 | 989a48bda98fbff398985397a6b1189a4cbc80e7 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.23e-07 | 147 | 216 | 8 | f6681c849c4c06154548bd29a094f202d1c946c2 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_vein-D175|Adult / Lineage, Cell type, age group and donor | 1.78e-06 | 169 | 216 | 8 | e1f0298236e4a1c59077c14f0dd29a78fac12648 | |
| ToppCell | -Donor_05|World / lung cells shred on cell class, cell subclass, sample id | 1.78e-06 | 169 | 216 | 8 | 8ebe9a88111c53a09c25a7b6a164a0a17880458d | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.63e-06 | 178 | 216 | 8 | ad3de3e03a401dac64431a541899445262246347 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.85e-06 | 180 | 216 | 8 | 1f1af4474f3f0ac3c0d6b1a6c875c354d36d8eec | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.97e-06 | 181 | 216 | 8 | 5f2d3a08577c440c944778d07aa993c6e7873f3d | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.97e-06 | 181 | 216 | 8 | c7c5f7d4c397b4613c772413a0a679377efffff3 | |
| ToppCell | CV-Moderate-7|Moderate / Virus stimulation, Condition and Cluster | 3.50e-06 | 185 | 216 | 8 | a6c9203ce6c2892a4a369c9bcfb85720f01cbb3f | |
| ToppCell | IPF-Myeloid-cDC1|World / Disease state, Lineage and Cell class | ANKRD20A2P NCKAP5 ANKRD20A3P ANKRD20A8P ANKRD20A4P MED12L CRYBG1 ANKRD20A1 | 3.64e-06 | 186 | 216 | 8 | 962c2dada19185628ead77c32fcb07fa95114247 |
| ToppCell | CV-Moderate-7|CV / Virus stimulation, Condition and Cluster | 3.64e-06 | 186 | 216 | 8 | 8571956890fc9894d766ba294a28e376b4aba428 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.94e-06 | 188 | 216 | 8 | b21e93a70583c30d05c0833cd3d4d4bca44a039e | |
| ToppCell | IPF-Myeloid-cDC1|Myeloid / Disease state, Lineage and Cell class | ANKRD20A2P NCKAP5 ANKRD20A3P ANKRD20A8P ANKRD20A4P MED12L CRYBG1 ANKRD20A1 | 3.94e-06 | 188 | 216 | 8 | 47bb6caf84f70a1cda7d09803afdfd5182772e66 |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.94e-06 | 188 | 216 | 8 | af740fa78542438fdff627ea1f74f4eee43316be | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.94e-06 | 188 | 216 | 8 | 874404a4fd9aa42873f6c53dc42da22d3b0fdb9e | |
| ToppCell | IPF-Myeloid-cDC1|IPF / Disease state, Lineage and Cell class | ANKRD20A2P NCKAP5 ANKRD20A3P ANKRD20A8P ANKRD20A4P MED12L CRYBG1 ANKRD20A1 | 3.94e-06 | 188 | 216 | 8 | 2331a2bae1383820d598e93aa86c75b101069bac |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.09e-06 | 189 | 216 | 8 | a153b83314cf52808f685296cff8c95af3f4983d | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.09e-06 | 189 | 216 | 8 | 2a22b9fae70afb3dab8476f9c00e48a4df756410 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.26e-06 | 190 | 216 | 8 | 841cd55861b43578d704418b9bc0af2e8b88323a | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.26e-06 | 190 | 216 | 8 | 30b50d183d7649146eb1e79b47ba897355f1998a | |
| ToppCell | E16.5-samps-Mesenchymal-Myofibroblast-Proliferative_Immature_MyoFibroblast|E16.5-samps / Age Group, Lineage, Cell class and subclass | 4.39e-06 | 135 | 216 | 7 | ed0f94d3839eea3b60217c4352159ed481361f13 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.60e-06 | 192 | 216 | 8 | 6f4ef24dab544681304b7f8a9dc073e7edaa4cf5 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.60e-06 | 192 | 216 | 8 | dcd924d6eb67d33ee9f5d3e8ab6e1d4283d6b708 | |
| ToppCell | LPS_only-Stromal_mesenchymal|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.60e-06 | 192 | 216 | 8 | 162d8b5858d150ecbbd1c9bf2b19c6c9cd50a158 | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Macrovascular_EC|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.78e-06 | 193 | 216 | 8 | 58c590dd6f21bc7ae58ae1729dd574c0f1069592 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.78e-06 | 193 | 216 | 8 | fb28717fadd06c3840636d25409ce80c9254bd34 | |
| ToppCell | Control-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 4.78e-06 | 193 | 216 | 8 | 5896242f713ae5fd1a4ebb63827f15d7279dced2 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.96e-06 | 194 | 216 | 8 | 6e13549f697f7478b34fe71f7dd9d63c5d3db22e | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.96e-06 | 194 | 216 | 8 | 89b706af2b25991fc2707eb24f49ba6ff3ae01f7 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 4.96e-06 | 194 | 216 | 8 | 71d3c7448b1734de54187f902f65649f9283bd4c | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.96e-06 | 194 | 216 | 8 | 60622bd2f75bfe4c37f721cb12f03dab33f2f58d | |
| ToppCell | IPF-Multiplet-Multiplet|IPF / Disease state, Lineage and Cell class | 5.15e-06 | 195 | 216 | 8 | fce0c29574bb7aab181b9c00feb42681e285d1f2 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.15e-06 | 195 | 216 | 8 | 803f714d91f2d97ecbee8c15a5139fd9310f66c7 | |
| ToppCell | NS-critical-LOC-Epithelial-Ciliated|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.15e-06 | 195 | 216 | 8 | 34e37cff4849696ca4ba5dd8fd2cf98fed8bc912 | |
| ToppCell | IPF-Multiplet|IPF / Disease state, Lineage and Cell class | 5.15e-06 | 195 | 216 | 8 | eacc0449ae6f3ad8002268cd061467684c6fb9a7 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.15e-06 | 195 | 216 | 8 | 4f70157d42a16ff0259bc24a62803c4df4285c44 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D122|Adult / Lineage, Cell type, age group and donor | 5.15e-06 | 195 | 216 | 8 | aa0add081881d349099d12efca5cdee098038d4e | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.15e-06 | 195 | 216 | 8 | df409f94f4e83be89f7a608058ee07ce3ce3a149 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell|Adult / Lineage, Cell type, age group and donor | 5.15e-06 | 195 | 216 | 8 | 61c9e09fc84d1012e472185d70ad0a06cee30d6e | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.15e-06 | 195 | 216 | 8 | 4243190ad291d56694e2155954dbaa879c9d3844 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.35e-06 | 196 | 216 | 8 | 2b36b9a40fe415917afccff99ad9c3474e087d0d | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Newborn-41|World / Primary Cells by Cluster | 5.35e-06 | 196 | 216 | 8 | dee0984cd63a1a2fdebb4421af48ab566a5b684e | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 5.35e-06 | 196 | 216 | 8 | 1450cb69c5bf469e97c03bf1890f6f7c54165b8a | |
| ToppCell | Children_(3_yrs)-Mesenchymal|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.35e-06 | 196 | 216 | 8 | bc94909f9b2dc08a59eef1914148b69720569c8f | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.35e-06 | 196 | 216 | 8 | 9737a5f006d37b549f281e1863aca558e1e4dc99 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.35e-06 | 196 | 216 | 8 | cecf82cd5e0a3835d655f5e7478578674a63ce25 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.35e-06 | 196 | 216 | 8 | 7d8505dac15fa59935ccf592afc54b04c4c6554f | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 5.55e-06 | 197 | 216 | 8 | fdb92985f7df0c280b87d3e43c2394e70786a2c7 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar-AT1|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.55e-06 | 197 | 216 | 8 | 8d5097898dd01cedb04cb694cb480c931e08462c | |
| ToppCell | PCW_13-14-Mesenchymal|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 5.55e-06 | 197 | 216 | 8 | 73a2085d2682d636726a5432d572ae2a3fbe1c3f | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 5.55e-06 | 197 | 216 | 8 | 0034bae02ee7fcfea520d453ca3c842ab6963b12 | |
| ToppCell | COVID-19-Fibroblasts|COVID-19 / group, cell type (main and fine annotations) | 5.55e-06 | 197 | 216 | 8 | fb847f2277609c31fffcdf49517243ce0684facf | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 5.55e-06 | 197 | 216 | 8 | 11a4c417f035e554431a8f03be13b5eefa3530c0 | |
| ToppCell | COVID-19-lung-Fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 5.76e-06 | 198 | 216 | 8 | df3de77216f5c5d6141ec44d01c56b942f611838 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Newborn-35|World / Primary Cells by Cluster | 5.76e-06 | 198 | 216 | 8 | de5214a85fe017eb23d4aa8af624464f062ec57e | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.76e-06 | 198 | 216 | 8 | 21cf4d81386761d09d0f6829c01c198e5524176d | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.76e-06 | 198 | 216 | 8 | f1374f7a50244d59c766ac41f44c08c9117407d2 | |
| ToppCell | nucseq-Mesenchymal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.76e-06 | 198 | 216 | 8 | 8f52243ca8b9ba68a75ae411506a3a6de258eb97 | |
| ToppCell | PSB|World / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.76e-06 | 198 | 216 | 8 | 4e6b0d1abc55d7a0d89bd7ecf0f13dc5bed66626 | |
| ToppCell | Mesenchymal|World / Lineage, Cell type, age group and donor | 5.98e-06 | 199 | 216 | 8 | 4bac110c2b3609f6ee5d0e3275da0824a6240270 | |
| ToppCell | PCW_10-12-Mesenchymal|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 5.98e-06 | 199 | 216 | 8 | a09292de4c4447b8eee55d401808e43b817321cc | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic-Fibroblastic_2|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.98e-06 | 199 | 216 | 8 | 66a79732caf2f04c09b4d9832377aa01ca477677 | |
| ToppCell | megakaryocytic-CD34+_Megakaryoblast|megakaryocytic / Lineage and Cell class | 5.98e-06 | 199 | 216 | 8 | 99a65887d3c8a2cde26693dd74404b101bba9d58 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 6.21e-06 | 200 | 216 | 8 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | NS-moderate-d_0-4-Epithelial|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.21e-06 | 200 | 216 | 8 | 64462a18afca3c1a8548a857924b8166058bf958 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Gen_Cap|LPS_only / Treatment groups by lineage, cell group, cell type | 6.21e-06 | 200 | 216 | 8 | eb94a5111ef0e903ee5be9f7efe571b4e6d5fce1 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Pericyte|Control_saline / Treatment groups by lineage, cell group, cell type | 6.21e-06 | 200 | 216 | 8 | cb7ef774b6d300f8019c5b16a04e3ebd165e4f1c | |
| ToppCell | NS-control|NS / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.21e-06 | 200 | 216 | 8 | ecbe89ff95d046155b984c8c150e0b9e7278f839 | |
| ToppCell | Control|World / group, cell type (main and fine annotations) | 1.83e-05 | 168 | 216 | 7 | a3511faf2cd2c2b9c8363c8b99da3f3609c43ed6 | |
| ToppCell | MS-CD8-proli_CD4|MS / Condition, Cell_class and T cell subcluster | 2.13e-05 | 172 | 216 | 7 | 0b6dd257110b3f17fa71ab18a165b091a9d5ae9a | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.21e-05 | 173 | 216 | 7 | 8888434641ea554a9b62c436e87920378eef29cd | |
| ToppCell | droplet-Liver-LIVER_HEPATOCYTES-30m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.38e-05 | 175 | 216 | 7 | 59249c9e83952d7277010e7be3c779e26399eb5d | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-PMP|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.38e-05 | 175 | 216 | 7 | a154b28b0b2180652d51d4c7d804b3b81b35899e | |
| ToppCell | droplet-Liver-LIVER_HEPATOCYTES-30m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.38e-05 | 175 | 216 | 7 | b35cc1357495f2a03a6500f807c6e6f8c877734d | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3-Exc_L2-3_LINC00507_RPL9P17|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.47e-05 | 176 | 216 | 7 | c7be4eaa5eb76ad9389fb9d15ad0934e88d267d1 | |
| Drug | LY294002; Down 200; 10uM; PC3; HG-U133A | DDX19A EVPL ADH6 MCM3AP EXOC7 EXOSC9 REXO4 PLEKHO2 SLIT3 ELAVL2 CDK6 | 2.78e-06 | 197 | 214 | 11 | 429_DN |
| Disease | response to cisplatin, platinum measurement | 3.22e-05 | 53 | 203 | 5 | EFO_0010154, GO_0072718 | |
| Disease | platelet measurement | HHEX STRN PURB MED12L UMPS PLCG2 JMJD1C ZFPM2 PLEKHO2 ANKDD1A | 7.11e-05 | 315 | 203 | 10 | EFO_0005036 |
| Disease | venous thromboembolism, fibrinogen measurement | 1.00e-04 | 67 | 203 | 5 | EFO_0004286, EFO_0004623 | |
| Disease | obsolete_red blood cell distribution width | ARHGAP42 UNC13D ADCY9 WNT5B STRN TMEM259 GTF2IRD2 CRYBG1 XRN2 KAT5 HECTD4 MKRN2OS PRC1 HEXD ZFPM2 GTF2IRD2B IGF2BP2 ZKSCAN1 RBM6 ELAVL2 SUMO3 RP1 | 1.62e-04 | 1347 | 203 | 22 | EFO_0005192 |
| Disease | diastolic blood pressure, alcohol drinking | 1.71e-04 | 118 | 203 | 6 | EFO_0004329, EFO_0006336 | |
| Disease | sexual dimorphism measurement | FILIP1 GAPVD1 ZNF142 EFCAB13 ADCY9 EXOSC9 LIMA1 KAT5 DNAH10 JMJD1C IGF2BP2 CATSPER1 CEP250 SLIT3 ASS1 NPRL3 RBM6 MACF1 CDK6 | 2.46e-04 | 1106 | 203 | 19 | EFO_0021796 |
| Disease | neutrophil-activating peptide 2 measurement | 2.80e-04 | 4 | 203 | 2 | EFO_0020606 | |
| Disease | CUB and Sushi domain-containing protein 2 measurement | 2.80e-04 | 4 | 203 | 2 | EFO_0803314 | |
| Disease | venous thromboembolism, plasminogen activator inhibitor 1 measurement | 3.89e-04 | 21 | 203 | 3 | EFO_0004286, EFO_0004792 | |
| Disease | lung carcinoma (is_marker_for) | 4.65e-04 | 5 | 203 | 2 | DOID:3905 (is_marker_for) | |
| Disease | venous thromboembolism, tissue plasminogen activator measurement | 5.13e-04 | 23 | 203 | 3 | EFO_0004286, EFO_0004791 | |
| Disease | body surface area | FILIP1 STIMATE ADCY9 EXOSC9 SLC44A2 ARHGEF12 DIDO1 IGF2BP2 SLIT3 ASS1 NPRL3 MACF1 CDK6 | 5.49e-04 | 643 | 203 | 13 | EFO_0022196 |
| Disease | Diffuse Large B-Cell Lymphoma | 5.64e-04 | 55 | 203 | 4 | C0079744 | |
| Disease | mean arterial pressure, alcohol drinking | 5.93e-04 | 98 | 203 | 5 | EFO_0004329, EFO_0006340 | |
| Disease | gamma-enolase measurement | 6.94e-04 | 6 | 203 | 2 | EFO_0021845 | |
| Disease | retinal detachment (implicated_via_orthology) | 6.94e-04 | 6 | 203 | 2 | DOID:5327 (implicated_via_orthology) | |
| Disease | mean platelet volume | HHEX CYP24A1 UNC13D JAK2 STRN PURB UMPS PLCG2 MICAL1 COL6A6 PRC1 NHP2 JMJD1C ZFPM2 ECHDC3 PLEKHO2 ANKDD1A | 7.33e-04 | 1020 | 203 | 17 | EFO_0004584 |
| Disease | immature platelet count | 8.47e-04 | 106 | 203 | 5 | EFO_0803544 | |
| Disease | Autoimmune Lymphoproliferative Syndrome Type 2B | 9.67e-04 | 7 | 203 | 2 | C1846545 | |
| Disease | transient cerebral ischemia (implicated_via_orthology) | 1.00e-03 | 64 | 203 | 4 | DOID:224 (implicated_via_orthology) | |
| Disease | hemoglobin A1 measurement | HHEX STIMATE UNC13D STRN NAA25 GULP1 PRC1 JMJD1C IGF2BP2 WSCD2 MACF1 | 1.01e-03 | 520 | 203 | 11 | EFO_0007629 |
| Disease | factor XI measurement, venous thromboembolism | 1.14e-03 | 30 | 203 | 3 | EFO_0004286, EFO_0004694 | |
| Disease | immature platelet fraction | 1.17e-03 | 114 | 203 | 5 | EFO_0009187 | |
| Disease | body weight | HHEX GAPVD1 NBEAL1 TTC1 TEX35 ADCY9 NAA25 CPSF2 EXOSC9 HECTD4 SLC44A2 ARHGEF12 FAS SH2B1 IGF2BP2 SLIT3 NPRL3 ELAVL2 CDK6 | 1.19e-03 | 1261 | 203 | 19 | EFO_0004338 |
| Disease | Prostatic Neoplasms | NBN UNC13D JAK2 UMPS CHD6 CNN3 MSH3 SF3B1 MYH14 P4HB PRKDC SPEN | 1.23e-03 | 616 | 203 | 12 | C0033578 |
| Disease | Malignant neoplasm of prostate | NBN UNC13D JAK2 UMPS CHD6 CNN3 MSH3 SF3B1 MYH14 P4HB PRKDC SPEN | 1.23e-03 | 616 | 203 | 12 | C0376358 |
| Disease | urate measurement, bone density | COL6A5 ITPKB STRN CPSF2 DNAH8 SNX29 ASS1 USP40 RBM6 ELAVL2 PRKDC SH3RF3 | 1.28e-03 | 619 | 203 | 12 | EFO_0003923, EFO_0004531 |
| Disease | Endotoxemia | 1.28e-03 | 8 | 203 | 2 | C0376618 | |
| Disease | Dickkopf-related protein 4 measurement | 1.28e-03 | 8 | 203 | 2 | EFO_0008110 | |
| Disease | Leukemia, Myelocytic, Acute | 1.30e-03 | 173 | 203 | 6 | C0023467 | |
| Disease | cardiovascular disease | ARHGAP42 EFCAB13 UNC13D ADCY9 ERAP2 DDX23 LIMA1 ZFPM2 NPRL3 CDK6 | 1.33e-03 | 457 | 203 | 10 | EFO_0000319 |
| Disease | Lymphoma, Non-Hodgkin | 1.37e-03 | 32 | 203 | 3 | C0024305 | |
| Disease | immature platelet measurement | 1.42e-03 | 119 | 203 | 5 | EFO_0803541 | |
| Disease | tissue plasminogen activator measurement, coronary artery disease | 1.47e-03 | 71 | 203 | 4 | EFO_0001645, EFO_0004791 | |
| Disease | coronary artery disease | ARHGAP42 NBEAL1 EFCAB13 UNC13D NAA25 UMPS PLCG2 DNAH10 PPP1R9A HECTD4 ARHGEF12 ZFPM2 IGF2BP2 ZKSCAN1 NPRL3 KIF4B RP1 SLC14A2 | 1.59e-03 | 1194 | 203 | 18 | EFO_0001645 |
| Disease | factor VIII measurement, venous thromboembolism | 1.64e-03 | 34 | 203 | 3 | EFO_0004286, EFO_0004630 | |
| Disease | Chronic schizophrenia | 1.64e-03 | 9 | 203 | 2 | C0221765 | |
| Disease | plasma renin activity measurement | 1.64e-03 | 9 | 203 | 2 | EFO_0006828 | |
| Disease | Cataract microcornea syndrome | 1.64e-03 | 9 | 203 | 2 | C1861829 | |
| Disease | rectum cancer (is_implicated_in) | 1.64e-03 | 9 | 203 | 2 | DOID:1993 (is_implicated_in) | |
| Disease | vascular endothelial growth factor A, isoform 121 measurement | 1.64e-03 | 9 | 203 | 2 | EFO_0020847 | |
| Disease | juvenile idiopathic arthritis | 1.72e-03 | 74 | 203 | 4 | EFO_0002609 | |
| Disease | monocyte percentage of leukocytes | HSP90B2P NEK6 ADCY9 JAK2 KIF3B COQ8A MCM3AP JMJD1C SNX29 EGFL6 ANKRD44 PRKDC CDK6 | 1.75e-03 | 731 | 203 | 13 | EFO_0007989 |
| Disease | unipolar depression | ABCA13 UNC13D ADARB1 ITPKB VNN2 CHD6 CACNA1E MICAL1 ITGA11 BAG5 SNX29 ZFPM2 ANKRD44 SF3B1 ELAVL2 KIF4B TRAV25 CACNA2D3 | 1.78e-03 | 1206 | 203 | 18 | EFO_0003761 |
| Disease | cerebrospinal fluid clusterin measurement | 1.79e-03 | 35 | 203 | 3 | EFO_0007657 | |
| Disease | systolic blood pressure, alcohol drinking | 1.96e-03 | 128 | 203 | 5 | EFO_0004329, EFO_0006335 | |
| Disease | CXCL5 measurement | 2.04e-03 | 10 | 203 | 2 | EFO_0009422 | |
| Disease | C-X-C motif chemokine 5 measurement | 2.04e-03 | 10 | 203 | 2 | EFO_0008058 | |
| Disease | venous thromboembolism, factor VII measurement | 2.27e-03 | 38 | 203 | 3 | EFO_0004286, EFO_0004619 | |
| Disease | lactate measurement | 2.44e-03 | 39 | 203 | 3 | EFO_0007745 | |
| Disease | meningitis | 2.49e-03 | 11 | 203 | 2 | MONDO_0021108 | |
| Disease | interstitial collagenase measurement | 2.49e-03 | 11 | 203 | 2 | EFO_0008193 | |
| Disease | platelet crit | NHSL2 MEF2D JAK2 NAA25 UMPS KAT5 ARHGEF12 NHP2 JMJD1C ZFPM2 IGF2BP2 PLEKHO2 ANKDD1A RP1 CDK6 | 2.56e-03 | 952 | 203 | 15 | EFO_0007985 |
| Disease | insulin measurement | 2.60e-03 | 267 | 203 | 7 | EFO_0004467 | |
| Disease | cancer (implicated_via_orthology) | 2.65e-03 | 268 | 203 | 7 | DOID:162 (implicated_via_orthology) | |
| Disease | lung non-small cell carcinoma (is_implicated_in) | 2.80e-03 | 139 | 203 | 5 | DOID:3908 (is_implicated_in) | |
| Disease | esophagus adenocarcinoma (is_marker_for) | 2.97e-03 | 12 | 203 | 2 | DOID:4914 (is_marker_for) | |
| Disease | congenital diaphragmatic hernia (implicated_via_orthology) | 2.97e-03 | 12 | 203 | 2 | DOID:3827 (implicated_via_orthology) | |
| Disease | vascular endothelial growth factor A measurement | 2.97e-03 | 12 | 203 | 2 | EFO_0010804 | |
| Disease | Dental enamel hypoplasia | 2.97e-03 | 12 | 203 | 2 | EFO_1001304 | |
| Disease | disks large homolog 3 measurement | 2.97e-03 | 12 | 203 | 2 | EFO_0802472 | |
| Disease | dickkopf‐related protein 1 measurement | 2.97e-03 | 12 | 203 | 2 | EFO_0010620 | |
| Disease | venous thromboembolism, von Willebrand factor measurement | 3.02e-03 | 42 | 203 | 3 | EFO_0004286, EFO_0004629 | |
| Disease | tyrosine-protein kinase receptor Tie-1, soluble measurement | 3.49e-03 | 13 | 203 | 2 | EFO_0008312 | |
| Disease | diabetic nephropathy | 3.88e-03 | 150 | 203 | 5 | EFO_0000401 | |
| Disease | C-X-C motif chemokine 11 measurement | 4.06e-03 | 14 | 203 | 2 | EFO_0008057 | |
| Disease | Majewski Syndrome | 4.06e-03 | 14 | 203 | 2 | C0024507 | |
| Disease | response to selective serotonin reuptake inhibitor, openness measurement | 4.06e-03 | 14 | 203 | 2 | EFO_0005658, EFO_0007914 | |
| Disease | calcium measurement | HHEX CYP24A1 TEX35 ITPKB SLC22A8 CCDC157 ZFPM2 LMX1A USP40 MACF1 CDK6 | 4.35e-03 | 628 | 203 | 11 | EFO_0004838 |
| Disease | cortical thickness | NBEAL1 NCKAP5 LRP8 STRN COL5A2 PRSS12 ARHGEF12 MSH3 JMJD1C SF3B1 LMX1A KCTD3 ELAVL2 MACF1 SH3RF3 CACNA2D3 | 4.54e-03 | 1113 | 203 | 16 | EFO_0004840 |
| Disease | glucose homeostasis measurement, glucose effectiveness measurement | 4.66e-03 | 15 | 203 | 2 | EFO_0006833, EFO_0006896 | |
| Disease | unipolar depression, autism spectrum disorder | 4.66e-03 | 15 | 203 | 2 | EFO_0003756, EFO_0003761 | |
| Disease | birth weight, pelvic organ prolapse | 4.68e-03 | 49 | 203 | 3 | EFO_0004344, EFO_0004710 | |
| Disease | diastolic blood pressure change measurement | 4.96e-03 | 50 | 203 | 3 | EFO_0006945 | |
| Disease | interferon gamma measurement, platelet-derived growth factor BB measurement, interleukin 4 measurement, interleukin 10 measurement, stromal cell-derived factor 1 alpha measurement, interleukin-6 measurement, interleukin 12 measurement, interleukin 17 measurement, vascular endothelial growth factor measurement, fibroblast growth factor basic measurement, granulocyte colony-stimulating factor measurement | 5.30e-03 | 16 | 203 | 2 | EFO_0004750, EFO_0004753, EFO_0004762, EFO_0004810, EFO_0008130, EFO_0008142, EFO_0008165, EFO_0008174, EFO_0008184, EFO_0008264, EFO_0008293 | |
| Disease | cystatin-F measurement | 5.30e-03 | 16 | 203 | 2 | EFO_0008104 | |
| Disease | epilepsy (implicated_via_orthology) | 5.51e-03 | 163 | 203 | 5 | DOID:1826 (implicated_via_orthology) | |
| Disease | white matter microstructure measurement | 5.81e-03 | 390 | 203 | 8 | EFO_0005674 | |
| Disease | interleukin 12 measurement | 5.84e-03 | 53 | 203 | 3 | EFO_0004753 | |
| Disease | partial epilepsy | 5.98e-03 | 17 | 203 | 2 | EFO_0004263 | |
| Disease | low density lipoprotein cholesterol measurement, body fat percentage | 5.98e-03 | 17 | 203 | 2 | EFO_0004611, EFO_0007800 | |
| Disease | ulcerative colitis (is_implicated_in) | 5.98e-03 | 17 | 203 | 2 | DOID:8577 (is_implicated_in) | |
| Disease | reaction time measurement | NCKAP5 STRN NAA25 PURB CC2D2A CHD6 DNAH10 PPP1R9A HECTD4 MSH3 ANKRD44 | 6.12e-03 | 658 | 203 | 11 | EFO_0008393 |
| Disease | diastolic blood pressure, alcohol consumption measurement | 6.15e-03 | 54 | 203 | 3 | EFO_0006336, EFO_0007878 | |
| Disease | noggin measurement | 6.70e-03 | 18 | 203 | 2 | EFO_0021995 | |
| Disease | triglycerides in large VLDL measurement | 6.80e-03 | 56 | 203 | 3 | EFO_0022178 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| DARVKEQRKGAGEKA | 96 | Q7Z4L5 | |
| VTNIQRGFIESGKKD | 761 | Q5TYW2 | |
| AGDKVGKLRVFVKNS | 471 | Q8IUX8 | |
| VTNIQRGFIESGKKD | 761 | Q5CZ79 | |
| VDTEGKGDIQQARKR | 56 | Q9UL15 | |
| KEEGQFQKRKTGRLQ | 396 | Q8NEC5 | |
| ALDIKIAKGGADRQQ | 1816 | Q15878 | |
| EGRSDGDSIKKIINQ | 541 | Q9P2I0 | |
| GVNTLQGFKEDKRNK | 381 | Q9NPI1 | |
| GAARIIGVDVNKEKF | 216 | P28332 | |
| VTNIQRGFIESGKKD | 761 | Q4UJ75 | |
| KGFQRGASQELKEAV | 326 | Q2KHT4 | |
| ENEAKVSTGKNRGRF | 531 | Q8IYW2 | |
| GKQTLKIFDGDDAVR | 296 | P52824 | |
| AAKDQFNEGRKGFDI | 1086 | Q99758 | |
| VEKEEKRVFEGRTNG | 4701 | Q86UQ4 | |
| RIEAEEAIKGLNGQK | 176 | Q14576 | |
| KVFKARDLKNGGRFV | 26 | Q00534 | |
| QFIEARLEKLNKGEG | 386 | Q8IV53 | |
| DKKFGVKARINGALN | 146 | Q9UPW5 | |
| AGKLEQALKQEQGAR | 311 | Q569K6 | |
| AEGKAREFKVGALRQ | 491 | A6NI56 | |
| ENGEIRFNGKGKKIR | 36 | P56179 | |
| FIRKQKEGNFDIVSG | 131 | O60762 | |
| LKGKGVINDVINDRF | 331 | Q9UN42 | |
| ANIGQKEDFEEARKK | 36 | P00966 | |
| IINQKRFNDGSDEKK | 226 | P25705 | |
| GDGAVNKEEKDVNLR | 1396 | Q9NZN5 | |
| KRDREGGESKLKFQE | 1726 | Q6ZS30 | |
| NFNGIKIKGRTIRVD | 96 | Q9Y388 | |
| DKIEEGQKKTFDGQR | 281 | Q8TBF8 | |
| GQKKTFDGQRTRQEE | 286 | Q8TBF8 | |
| NENRVKIGDFGLTKV | 986 | O60674 | |
| TNKGEVFNELVGKQR | 226 | P05556 | |
| ETAQKTGVFQLKDRG | 11 | Q8N9N7 | |
| VTNIQRGFIESGKKD | 761 | Q5SQ80 | |
| QQKKSGEVAVLKRDG | 61 | Q9Y530 | |
| GEALQKAIEEDKQRG | 221 | P19113 | |
| EDLKGARGNLTKNQE | 21 | Q8IVN3 | |
| ENVRDKKKGNIFIGI | 376 | P20585 | |
| EFDGKRFQNVAKEGV | 221 | Q58FF3 | |
| ENKKEGRVEVFINGQ | 506 | P56730 | |
| KEKAKENGGNRHREG | 201 | Q8TDR0 | |
| GDEGQKARKNKQETF | 766 | Q86YW9 | |
| KERDNDTKVKRGAGN | 266 | Q14676 | |
| VGGRVAERKQVENAK | 626 | Q9UHB6 | |
| KRKGGQVRFSNDQTI | 136 | Q03014 | |
| KDQDGKITRQEFIDG | 7211 | Q03001 | |
| RNLIFNGKLDKGDRE | 596 | O60303 | |
| GFEEVSKRQKNKSGE | 2241 | Q15652 | |
| FKSRDQRGVQEEKVK | 1201 | Q8IYD8 | |
| FKSNKEVGRLGNKEA | 346 | O60318 | |
| GELEVFQKDGERKIQ | 101 | Q8WW38 | |
| QEKLFGEKGSDRFRQ | 231 | Q14C86 | |
| KGTISFFEIDGRKNK | 296 | Q92993 | |
| RDGQEGITAFLQKRK | 281 | Q96DC8 | |
| NRLGRKGIKQEAFKD | 221 | Q99645 | |
| NDQKVRKEGGKFGFA | 271 | Q06265 | |
| ASAGQGKEEAVKQLR | 1651 | Q7Z406 | |
| LEEAEQAALRGGKKQ | 1846 | A7E2Y1 | |
| ERQLQKGDEFVLKEG | 126 | Q8TE12 | |
| IVDQKQGKGSRAADK | 26 | Q8IYB4 | |
| KAQVEEEGKRRAGLQ | 976 | Q92817 | |
| KQEGRLAVANAELGK | 3296 | Q96JB1 | |
| GQKFELKIDNVRFVG | 81 | Q12980 | |
| LRGGFDEDVKAKVEN | 326 | Q8WVB3 | |
| QETKGGAANRKLAEE | 81 | Q8TBE9 | |
| SLADFQIEKKIGRGQ | 41 | Q9HC98 | |
| IGRSQGADKDLAAKE | 2086 | O94854 | |
| KQAGLEEDFVRNKGQ | 571 | Q96MY7 | |
| VGKKDEEQAALGQKR | 186 | Q1ED39 | |
| RAKENAEDAGGKKLR | 646 | Q8TDZ2 | |
| RGKREGFFLKSVENA | 711 | O75676 | |
| GAAAREKELVNVKKG | 251 | P50222 | |
| AKGANINAFDKKDRR | 161 | Q8N8A2 | |
| KNKDTAEQVGKEGRS | 211 | Q8N8V4 | |
| FKAQGRIFGKLKEEN | 486 | Q9Y6M1 | |
| IEFARSEAFQKGGRK | 246 | Q9UKX5 | |
| DGVVLFKKFDEGRNN | 201 | P07237 | |
| GKNSKDFERAKAVRQ | 76 | P16885 | |
| AVFKINDRDSGENGK | 366 | Q9UN67 | |
| RGFIAGIDLKQQKRE | 301 | Q9BUQ8 | |
| NEAERKSGLDQIKGA | 2271 | Q9Y4D8 | |
| FGRKQGSSKEEQERK | 776 | P78316 | |
| FQKSERGGFRLKENV | 426 | P78563 | |
| EGKQAKVLENAEGAR | 71 | P38646 | |
| VDRKQGAKLNFKEGL | 891 | Q6NV74 | |
| DKERQIIKERFKGFN | 646 | Q9UPT5 | |
| GQFKSRKEREAELGA | 171 | Q9H361 | |
| KNKRRNFGQIVSDVG | 21 | Q8NH94 | |
| IFAFARIRQKQKEGG | 1966 | Q9UMZ3 | |
| VTNIQRGFIESGKKD | 761 | Q5VUR7 | |
| FKKDDIGRRNGQAPN | 91 | P57076 | |
| KNIFDEKGNKRFGAT | 541 | Q9ULG6 | |
| EKGNKRFGATKEAAE | 546 | Q9ULG6 | |
| GDKAVFRARVQGNAK | 81 | Q8N9C0 | |
| KGRKKVTAQNLSDGD | 1026 | Q9P2K1 | |
| LKEKRKQFIRSVGEG | 6 | Q5XLA6 | |
| EKRFGLLQKNAGDEA | 221 | Q07973 | |
| GNVRAIKRKSEEGNV | 336 | Q6ZNI0 | |
| INERDKDGNFLELGK | 136 | Q8IZS8 | |
| SREKNQGFQDETKKG | 1901 | Q8TD26 | |
| NGGDLQKRVAEKASD | 161 | I3L3R5 | |
| KVSLKGNRESDGFRE | 441 | Q9NYF8 | |
| VKKADVGRDRVQFGA | 841 | A8TX70 | |
| KFLESGGKDVETRKQ | 151 | Q9UBP9 | |
| GQEERVKEKADALQG | 1831 | Q9BV73 | |
| GGLTAEDIEKARQAK | 171 | Q8NI60 | |
| SEDQGIKGRIEKAAN | 361 | Q9BTC0 | |
| VKAEERGRFGKAIEK | 1316 | O60503 | |
| KGANDLDIKAEGNIR | 1426 | P05997 | |
| RLTIFEQENFLGKKG | 106 | P53673 | |
| GKNLEDFLRNVGIKS | 691 | Q8IY85 | |
| RIEAEEAIKGLNGQK | 176 | Q12926 | |
| KGLAENEENKGFLRN | 271 | Q4ZIN3 | |
| KKDGAVRVAQSLQGE | 466 | O75578 | |
| KDFLGEEKFQKGIIQ | 466 | Q6P179 | |
| KAEGDRLKEGININR | 251 | O95239 | |
| KAEGDRLKEGININR | 251 | Q2VIQ3 | |
| EGAKKANGVLEARQL | 206 | Q8IWA5 | |
| DEKQLIIDAGQKRFG | 601 | Q5FWF5 | |
| GGVEEKAKNNAVLLR | 211 | O75521 | |
| INDKENRDVTNGGIK | 811 | Q9Y4K1 | |
| AVRGNKLERGQKISE | 196 | Q9NUU7 | |
| VGKRKIDQEGRVFQE | 416 | Q86UP8 | |
| VGKRKIDQEGRVFQE | 416 | Q6EKJ0 | |
| KVSQGRQFIILGDKE | 3501 | Q8IVF4 | |
| LRRVAVFNGKKEEGE | 276 | Q8TCC7 | |
| VFNGKKEEGERLSLE | 281 | Q8TCC7 | |
| ENENKIEFRKKGGFE | 746 | Q9Y597 | |
| RRGVKEVQKFVNKGE | 61 | Q9NX24 | |
| TGVEQGRLIFDNLKK | 771 | P20648 | |
| GGERDKASFLQTVQK | 81 | Q9BQ95 | |
| VKKADVGKNQVRFGA | 836 | A6NMZ7 | |
| KQNAKGRFLKIAEVG | 51 | Q96QR8 | |
| DQAKIEKSGLNGVDR | 561 | Q14114 | |
| NADIIETLRKKGFNG | 81 | Q14814 | |
| DFGEKQKNALGEAAR | 146 | Q0VDF9 | |
| AVFKIKDRDSGENGK | 366 | Q9Y5E1 | |
| AEKAEAIRKIGFGTN | 306 | Q6QHF9 | |
| KQKRINFLGLEEEGN | 2006 | P56715 | |
| KKDREQRGQENTSGF | 241 | Q9Y6R4 | |
| EAAKIARKQLGQSEG | 211 | Q9GZR2 | |
| DGKEKKDRGVTRFQE | 851 | P78332 | |
| AAAAKERQEKEKAGG | 671 | Q9NRF2 | |
| IAFLQGERKGQENLK | 81 | O43815 | |
| KAIGNKDAKFVEERR | 721 | Q8TEQ0 | |
| LGKKGRGKEAEEQRQ | 926 | A5PKW4 | |
| VDGLNKNFKVEQGKV | 526 | Q7Z7B0 | |
| DAKVLGFGNRQLKSE | 1536 | O14513 | |
| GRNDDFKALLQKKGS | 1171 | Q5HYW2 | |
| DLSGRQERKQIFKGK | 211 | O60934 | |
| LEKFRKEQIGAAKDG | 116 | A6NI28 | |
| FLSKIQDDFRGGKIN | 6 | Q86YW0 | |
| QDDFRGGKINLEKTQ | 11 | Q86YW0 | |
| GDKLQCVQKGEKEGR | 91 | P09455 | |
| EKIQENVRNAIGGKF | 406 | Q06033 | |
| FRIEGIKKEDGTVNR | 811 | P27987 | |
| RIGNAKGDDALEKRF | 306 | Q9Y617 | |
| ALKNQGFKIIERGEI | 536 | O75343 | |
| NRFTNRGGNLLKEEK | 376 | O43663 | |
| KNAAKTRREKENGEF | 6 | Q14190 | |
| QGEEKEKGAQEKRRG | 291 | Q5C9Z4 | |
| NVKNGIRTGFLKIDE | 101 | O75688 | |
| KRGDGFVNESRLQKI | 321 | P59797 | |
| QQVLKGRGKFAQDVS | 126 | Q96H20 | |
| AGVDLNLRDKQGKTA | 346 | Q495B1 | |
| QVLKFRKLNFNGEGE | 221 | P00918 | |
| AKEKIEGRSQGNDIL | 1441 | P42695 | |
| EKQTRRFDEGKLKAG | 146 | Q15417 | |
| VAGQDGSVVQFKIKR | 21 | P55854 | |
| DQEGEKKRKGGRNFQ | 281 | O75475 | |
| NNKIKEVREGAFDGA | 566 | O75094 | |
| KESQRDDGKGALNIV | 2756 | A4UGR9 | |
| DDGKGALNIVEFLRK | 2761 | A4UGR9 | |
| FEVLKDGRLVNKNGS | 456 | O95498 | |
| GTDVKQLDQGNKDVR | 366 | Q8N0X7 | |
| ENVNRKEKGELSAGN | 361 | Q96F44 | |
| AQVVKNLAEKKGEFR | 41 | Q9NUD5 | |
| EQGIQDSFKKATLGR | 56 | Q8TB69 | |
| KIGGNKIKVDFANRE | 576 | Q96T58 | |
| AEGRQQLDKGEFTEK | 166 | H3BPM6 | |
| ADKAGKRFDGKLQSE | 41 | P42285 | |
| DRGNKRIQVFDKDTG | 231 | Q5JS37 | |
| AQNRKAIVDKFGGAA | 346 | A8MU46 | |
| EGSKEAQKVKFQLER | 651 | Q5VU36 | |
| KGFVRKNGVNEAKID | 246 | P25445 | |
| RQAKTGAQGERLKEA | 251 | O15066 | |
| GAVSAFQRRVDGKKN | 361 | Q8TEJ3 | |
| REIQGKKAALDEAQG | 16 | O75533 | |
| SGGQDSRRFKVNVKV | 431 | P35590 | |
| QDKENFVGVNNKRLG | 11 | Q8TAV4 | |
| EEEQDGFIRVLSGKK | 376 | Q99469 | |
| EKQRVREEILAKGGF | 131 | Q9H0D6 | |
| EDRKFADIGNTVKKQ | 311 | P11172 | |
| REKNFAKGSEEQGRV | 181 | Q9H1J7 | |
| QVAEKLEAFLGRKGD | 131 | Q96LD8 | |
| FRKEQAQGKVNVFGR | 1751 | Q9P273 | |
| GKTKAKLEERGANQD | 221 | Q86TL2 | |
| KVGTRGKKQIFEENR | 6 | Q9BTX3 | |
| EVDNKVKGAAGRTDL | 2711 | P78527 | |
| EEQIKRNAAGKDGKE | 241 | Q9NRL3 | |
| GEVKKQKRLTFQFGE | 71 | A0A0B4J276 | |
| EGINRGKNKAFDEVK | 116 | Q8TD55 | |
| RSQKEFGEKRDQEGK | 296 | P17029 | |
| FGEKRDQEGKTGERQ | 301 | P17029 | |
| GDTVLVQKQKGARFS | 1091 | P52746 | |
| ESQKDGNFKRSGLRK | 511 | Q2TBF2 | |
| KRTKGQRDAERVGEN | 211 | Q5VZ18 | |
| STRLKEEGNEQFKKG | 116 | Q99614 | |
| QRGGLLQFEADKTAK | 171 | Q9HAV5 | |
| GRFTKAGVTQDLKNE | 41 | Q5T0J7 | |
| KVFGKGEHQERQNKD | 491 | Q15849 | |
| VNVNKIKDFGEAAKR | 421 | Q96QC0 | |
| RDDTGKEKQKQRALG | 1181 | Q9NVE5 | |
| KFAQKEETLAQRGEK | 1636 | Q6ZQQ6 | |
| KEARKDKGQDDFLGN | 231 | Q70J99 | |
| KGEFGSVREAQLKQE | 526 | Q06418 | |
| VQGIKGFEAEFKRSQ | 76 | A0A0A6YYJ7 | |
| EGRGIAQEQLFQEKK | 1016 | Q70EL1 | |
| KAIGLQRTGKQEEAF | 51 | Q14CX7 | |
| AAKQQRKELAGGDFT | 356 | Q9ULJ8 | |
| EGTQAVLRAKKGQDD | 151 | Q15223 |